Schober, S; Wawer, A; von Luettichau, I; Salat, C; Issels, R; Urban, C; Burdach, S; Thiel, U.
Donor lymphocyte infusion after allogeneic stem cell transplantation is a feasible therapy option with acceptable toxicity rates in patients with advanced Ewing sarcoma and rhabdomyosarcoma
ONCOL RES TREAT. 2018; 41: 131-131.
[Oral Communication]
Web of Science